2. Academic Validation
  3. Antimycin A inhibits alpha-herpesvirus replication by disrupting the formation of pyrimidinosomes

Antimycin A inhibits alpha-herpesvirus replication by disrupting the formation of pyrimidinosomes

  • J Adv Res. 2025 May 10:S2090-1232(25)00309-1. doi: 10.1016/j.jare.2025.05.016.
Yong-Qi Guo 1,  Meng-Hang Wang 1,  Ning Tang 2,  Yu-Bo Zhao 1,  Li-Jing Wo 1,  De-Xin Liang 1,  Rui Huang 1,  Yan-Dong Tang 3,  Ying-Jie Sun 4,  Xin Yin 5
Affiliations

Affiliations

  • 1 State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • 2 Shanghai Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Shanghai, China.
  • 3 State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China. Electronic address: tangyandong@caas.cn.
  • 4 Shanghai Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Shanghai, China. Electronic address: sunyingjie@caas.cn.
  • 5 State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China. Electronic address: yinxin@caas.cn.
PMID: 40354935 DOI: 10.1016/j.jare.2025.05.016
Abstract

Introduction: Alpha-herpesvirus poses significant health risks to humans and challenges to Animal Husbandry. Currently, the clinically approved Antiviral drug Acyclovir exhibits limitations, including drug resistance and adverse effects. The development of broad-spectrum Antiviral agents against alpha-herpesvirus is urgently needed.

Objective: This study aimed to discover a novel Antiviral drug with the capacity to broadly inhibit various alpha-herpesviruses.

Methods: In this study, we conducted a high-content screening of 1,500 chemical compounds to identify potential Antiviral candidates. The Antiviral mechanisms were explored using phenotypic experiments, untargeted metabolomics, and molecular docking.

Results: We discovered that Antimycin A effectively inhibits the replication of various alpha-herpesviruses, including herpes simplex virus 1 (HSV-1), bovine herpesvirus 1 (BHV-1), and pseudorabies virus (PRV). Our study revealed that Antimycin A inhibits viral replication by disrupting the formation of pyrimidinosomes that are essential for efficient viral Infection. Finally, Antimycin A effectively inhibited viral Infection, prevented tissue damage, and enhanced survival in PRV-infected BALB/c mice, confirming its in vivo efficacy.

Conclusion: Antimycin A emerges as a promising lead candidate for the development of Antiviral therapies against alpha-herpesvirus infections.

Keywords

Alpha-herpesviruses; Antimycin A; DHODH; Pyrimidinosomes; VDAC3.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z